Chris Smith

Gyrus Medical Ltd. manufactures medical devices. It makes instruments used in minimally invasive surgical procedures which primarily focus on products used by general surgeons. The company is located in Cardiff, UK.

Startek, Inc. engages in the provision of global customer experience solutions. Its solutions help global companies to connect emotionally with their customers, solve issues, and improve net promoter scores and other customer-facing performance metrics. The company offers multiple services, including sales, order management and provisioning, customer care, technical support, receivables management, and retention programs. It also manages programs using a variety of multi-channel customer interactions, including voice, chat, email, social media and back-office support. It operates through the following geographical segments: Americas, Malaysia, India and Sri Lanka, Australia, South Africa, and Rest of World. The company was founded by A. Emmet Stephenson and Michael W. Morgan in 1987 and is headquartered in Denver, CO.

ev3, Inc. is a provider for specialists treating a range of vascular diseases and disorders. ev3 is committed to the peripheral vascular and neurovascular markets offering a portfolio of treatment options, including interventional technologies used such as plaque excision systems, PTA balloons, stents, embolic protection, thrombectomy, embolization coils, liquid embolics, occlusion balloons and procedural support.

Acclarent, Inc. engages in manufacturing, designing, and commercializing medical devices that address conditions affecting the ear, nose, and throat. Its products include balloon sinuplasty, eustachian tube dilation, airway dilation system, and ethmoid punch. The company was founded by Joshua Makower and John Y. Chang in June 2004 and is headquartered in Irvine, CA.

Akouos, Inc. is a precision genetic medicine company, which engages in the development of precision genetic medicines to restore and preserve hearing in genetically-defined patient populations. The firm's lead product candidate, AK-OTOF, is a gene therapy for the treatment of hearing loss due to mutations in the OTOF gene. It develops targeted adeno-associated viral vector based gene therapies for sensorineural hearing loss, which results from dysfunction or damage to sensory cells and nerve fibers of the inner ear. The company was founded by Emmanuel J. Simons, William F. Sewell, Richard H. Smith, Luk H. Vandenberghe, and Michael J. McKenna on March 7, 2016 and is headquartered in Boston, MA.

Neuromod Devices Ltd. operates as a medical device company which engages in the research and development of neuromodulation technologies for chronic tinnitus. The firm develops proprietary neuromodulation technologies designed to address pathologies, which are believed to give rise to illusory perceptions, such as tinnitus. These technologies utilize bi-modal neuromodulation and aim to promote positive therapeutic change within the human nervous system. The company was founded by Ross O?Neill in 2010 and is headquartered in Dublin, Ireland.

Ortho-Clinical Diagnostics, Inc. engages in the manufacture and design of diagnostic, transfusion, clinical equipment, and systems. It provides solutions for screening, diagnosing, monitoring, and confirming diseases early before they put lives at risk. Its products include instrument systems and reagents that screen for AIDS and hepatitis C, as well as blood typing systems. The company was founded in 1939 and is headquartered in Raritan, NJ.

Agilitas USA, Inc. engages in the provision of physical therapy services. The treatments it offers include dry needling therapy, manual therapy, and pelvic health speciality clinics. The company was founded by Garry Cunningham, Gregory Spurgin, and Tracy Caulkins in 1996 and is headquartered in Franklin, TN.

Ortho-Clinical Diagnostics Italy Srl manufactures and designs diagnostic, transfusion, and clinical equipment and systems. The firm provides total solutions for screening, diagnosing, monitoring and confirming diseases early before they put lives at risk. The company is headquartered in Milan, Italy.

Ortho Clinical Diagnostics Holdings Plc provides vitro diagnostics services. It offers VITROS XT 7600 Integrated System, VITROS 5600 Integrated System, VITROS 4600 Chemistry System, VITROS® XT 3400 Chemistry System, VITROS® 3600 Immunodiagnostic System, VITROS ECiQ Immunodiagnostic System, VITROS Automation Solutions, Informatics Solutions, Assay Menu by Disease State, Microtip Partnership Assays, VITROS HIV Combo Test, Transfusion Medicine, ORTHO VISION Analyzer, ORTHO VISION Max Analyzer, ORTHO CONNECT, ORTHO Workstation, Lab Reliability, Lab Optimization, Training & Education and Lab Support. The company was founded in 1997 and is headquartered in Raritan, NJ.

Osler Diagnostics Ltd. engages in research and development in biotechnology. The company was founded by Jason Davis and Paulo R. Bueno and is headquartered in Oxford, the United Kingdom.